| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6124758 | Osteoarthritis and Cartilage | 2016 | 60 Pages |
Abstract
In patients with multiple comorbidities, naproxen- and ibuprofen-containing regimens are more effective and cost-effective in managing OA pain than opioids, celecoxib or SOC.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
J.N. Katz, S.R. Smith, J.E. Collins, D.H. Solomon, J.M. Jordan, D.J. Hunter, L.G. Suter, E. Yelin, A.D. Paltiel, E. Losina,